AAArmando Arredondo

Armando Arredondo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Armando Arredondo has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Análisis costo-efectividad de alternativas de tratamiento para osteoporosis en mujeres postmenopáusicas en México

    by Frida Alejandra Flores-Silva, Sayra Melisa Diaz-Solis, Abel Armando Arredondo-López

    Objective: To identify the most cost-effective treatment for osteoporosis in the prevention of hip fractures in postmenopausal Mexican women without social security in the first level of care. Material and Methods: A cost-effectiveness analysis was performed for three osteoporosis treatment schemes selected for their different administration routes and dosage. The treatments were estimated for a one-year period. The costs of each intervention were estimated from the provider’s perspective and the prices from the Mexican market available for July 2021 were considered. Treatment effectiveness was determined from previous studies on the effect of each treatment on the prevention of hip fractures. The cost-effectiveness coefficient was calculated for each treatment. Results: The most cost-effective treatment was 10 mg alendronate, a daily oral treatment, with a $188,548.61 USD cost, a 55% effectiveness and a 0.0377 cost-effectiveness coefficient. Treatment with denosumab was the most expensive ($725,625.05 USD) and the least effective (C-E coefficient 0.1814), zoledronic acid had a $377,291.92 USD cost and a 0.0920 C-E coefficient. Conclusions: Alendronate is the most cost-effective treatment of osteoporosis for the prevention of hip fractures in postmenopausal women and should be recommended as the first-line treatment in these patients. Keywords: Cost-effectiveness; Osteoporosis; Postmenopause; Alendronate; Primary health care

  • Open Access

    Costo-efectividad del tratamiento con insulina para el control de diabetes mellitus tipo 2 en México

    by Pablo López-Esteves, Felipe Rangel-Osuna, Jair Yañez-Santaolalla, Amairani Hernández-Castro, Abel Armando Arredondo-López

    Objective: To identify the best cost-effective intervention for the treatment of type 2 diabetes mellitus, at the first level of care, when the patient requires the use of insulin, based on previous clinical analysis. Materials and methods: A cost-effectiveness analysis was carried out, from the provider perspective. The cost of three types of insulin as a control drug were obtained: glargine insulin, neutral protamine Hagedorn (NPH) insulin and lispro insulin/lispro protamine 25-75 IU. The effectiveness indicators were obtained from previous studies that analyzed the effect on glycated hemoglobin (HbA1c). Results: The intervention that presented the best cost-effective coefficient was the treatment with glargine insulin, with a value of 570, compared to 643.1 for the NPH insulin and 57 for the lispro/lispro protamine insulin. Conclusions: Glargine insulin is the treatment in patients who require insulins, without microvascular damage, that presents the best evidence to invest in, because of its cost and efficiency (analyzed through a cost-efficiency coefficient). These results may be considered in the Mexican context to improve drug’s acquisition and the treatment standards to treat type 2 diabetes mellitus. Key words: Type 2 diabetes; Cost-effectiveness; Insulin

  • Open Access

    Factores socioculturales de la vulnerabilidad al sobrepeso durante los primeros años de vida en México

    by Emanuel Orozco-Núñez, Christian Paul Torres-De la Rosa, Óscar Reséndiz-Lugo, Selene Pacheco-Miranda, Rubén Chávez-Ayala, Nadia Cerecer-Ortiz, Armando Arredondo-López

    Objetivo. Analizar el rol de los factores socioeconómicos y culturales en la vulnerabilidad a la obesidad en madres y sus hijos menores de dos años, en localidades del Sur de Morelos, México. Material y métodos. Se realizó trabajo de campo y observación no participativa. Durante 2019, se aplicaron 17 entrevistas semiestructuradas a una submuestra de una cohorte. Los datos fueron ordenados y analizados con apoyo del software Atlas-Ti v. 7, usando 18 códigos libres. Resultados. Factores sociales como los ingresos del hogar y los roles de género, combinados con la influencia de la parentela y las creencias sobre la preferencia de la niñez por productos ultraprocesados, predisponen la disponibilidad de bebidas y alimentos calóricos que generan vulnerabilidad a la obesidad durante la infancia temprana. La actividad eco­nómica de las madres, la participación de los padres y evitar influencia de parientes puede predisponer una mejor calidad de los alimentos y mayor actividad física. Conclusiones. La baja disponibilidad de alimentos saludables, los riesgos de inseguridad alimentaria y los factores familiares y culturales, que se presentan en contextos de vulnerabilidad económica y social, incrementan la vulnerabilidad del binomio madre-hijo a la obesidad.


  • Determinantes de la inseguridad alimentaria y su asociación con prácticas de alimentación y lactancia materna en el primer año de vida

    by Oscar Reséndiz, Christian Torres, Armando Arredondo, Yair García, Emanuel Orozco

    Resumen Objetivo: analizar los determinantes de la Inseguridad Alimentaria (IA) y su relación con las Prácticas de Alimentación (PA) y las Prácticas de Lactancia Materna (PLM) en el primer año de vida. Métodos: análisis de tipo cuantitativo sobre el binomio madre-hijo de una cohorte en México. Los datos de interés fueron el estado de seguridad alimentaria (SA), las PA y las PLM. Se desarrolló un modelo de regresión para evaluar determinantes asociados a la IA y un análisis de medias para determinar el impacto de la IA en las PA y las PLM. Resultados: el 54.1% de hogares presentó algún grado de IA. Las madres con pareja (OR = 0.25; p = 0.05) y con escolaridad superior (OR = 0.50; p = 0.04) tuvieron menor riesgo de padecer IA. En contraste, los hogares con mujeres mayores de 25 años estuvieron más expuestos a la IA (OR = 3.0; p = 0.00). Los hogares con IA introducen alimentos no recomendados como dulces, galletas o pastelitos ( p = 0.00) y bebidas no lácteas azucaradas ( p = 0.05) de forma prematura. Conclusiones: la IA requiere mayor atención por sus efectos en las PA y las PLM, las cuales son consideradas como factores asociados al desarrollo de mala nutrición.


  • Open Access

    Costo-efectividad del tratamiento de diabetes tipo 2 en primer nivel de atención

    by Martín Figueroa-Gaspar, Eréndira Marín-Mendoza, Érika Chávez-Briseño, Abel Armando Arredondo-López

    Objective: To identify the most cost-effective treatment in three main schemes for type 2 diabetes mellitus outpatients in a first level care unit in the Morelos State. Materials and Method: In a sample of 1795 patients treated in a first-level unit, the cost-effectiveness coefficient calculation was performed for three treatment schemes, selected as part of the stepped treatment suggested in the main guides and for their availability at the first level of care. Costs of each intervention were calculated using the instrumentation estimation method and the average case management technique. A search was carried out in PubMed, Scopus, Scielo and Latindex databases based on keywords, and a review of the literature was made where the efficacy of the treatment schemes of interest was evaluated and the effectiveness was determined from the effect of the drugs of each intervention, compared to the effects of diet and other hypoglycemics. To identify the decision rule, the cost-effectiveness coefficient of each intervention was determined. Results: The most cost-effective intervention was based on a combined oral treatment of metformin with glibenclamide, obtaining a total cost of $951.75 USD, with an effectiveness rate of 42.30% and an effectiveness coefficient of 2.25. Conclusions: For the first level of care, it is recommended to promote more the use of combined oral treatment of metformin with glibenclamide. Keywords: Cost Effectiveness; Drug Therapy; Diabetes Mellitus; Primary Health Care.


  • Open Access

    An estimate of the economic burden of schizophrenia in Mexico: a retrospective study in the psychiatric hospital setting

    by Héctor Cabello-Rangel, Armando Arredondo, Lina Díaz-Castro, Hortensia Reyes-Morales, María Elena Medina-Mora

    Background: The aim of the present study was to estimate the economic burden from the perspective of patients and their families and the associated variables. Methods: Quantitative evaluative research with retrospective design of patients with schizophrenia diagnosis according to the International Classification of Diseases (ICD-10). Direct costs (medical and out-of-pocket costs), non-medical costs (transportation) and indirect costs were calculated. Findings: A sample of 96 patients was obtained; 62% were males, the median of treatment was 7.5 years (Interquartile range, IQR 13), the mean schooling was 10 years (standard deviation, SD 2.7). The 71.8% of study sample had no work activity. Direct costs: medical costs USD 2,956 and out-of-pocket expense USD 498. Non-medical costs USD 10. Indirect costs: the productivity loss of the patient was USD 5,760 and for the family caregiver was USD 460. The annual illness cost of a case of schizophrenia was USD 7,164; considering the prevalence of schizophrenia, the annual economic burden was USD 206,625,079 in total. There is a negative association between the loss of productivity of the patient with age, occupation and years of treatment evolution, Coefficients -.318, P < 0.05; -.431, P < 0.001; -.428, P < .000; respectively. Conclusions: The economic burden of schizophrenia in Mexico was determined by the loss of productivity and out-of-pocket expenses; the determinants were work activity and the years of evolution of the disorder. It is necessary to establish mechanisms for financial protection and timely care of the schizophrenia in order to achieve the patient’s reintegration into the labor market.

  • Open Access

    An estimate of the economic burden of schizophrenia in Mexico: a retrospective study in the psychiatric hospital setting

    by Héctor Cabello-Rangel, Armando Arredondo, Lina Díaz-Castro, Hortensia Reyes-Morales, María Elena Medina-Mora

    Background: The aim of the present study was to estimate the economic burden from the perspective of patients and their families and the associated variables. Methods: Quantitative evaluative research with retrospective design of patients with schizophrenia diagnosis according to the International Classification of Diseases (ICD-10). Direct costs (medical and out-of-pocket costs), non-medical costs (transportation) and indirect costs were calculated. Findings: A sample of 96 patients was obtained; 62% were males, the median of treatment was 7.5 years (Interquartile range, IQR 13), the mean schooling was 10 years (standard deviation, SD 2.7). The 71.8% of study sample had no work activity. Direct costs: medical costs USD 2,956 and out-of-pocket expense USD 498. Non-medical costs USD 10. Indirect costs: the productivity loss of the patient was USD 5,760 and for the family caregiver was USD 460. The annual illness cost of a case of schizophrenia was USD 7,164; considering the prevalence of schizophrenia, the annual economic burden was USD 206,625,079 in total. There is a negative association between the loss of productivity of the patient with age, occupation and years of treatment evolution, Coefficients -.318, P < 0.05; -.431, P < 0.001; -.428, P < .000; respectively. Conclusions: The economic burden of schizophrenia in Mexico was determined by the loss of productivity and out-of-pocket expenses; the determinants were work activity and the years of evolution of the disorder. It is necessary to establish mechanisms for financial protection and timely care of the schizophrenia in order to achieve the patient’s reintegration into the labor market.


  • Open Access

    Breastfeeding and feeding practices in the first year of life and its association with overweight and obesity of children in Mexico

    by Armando Arredondo, Oscar Benjamin Reséndiz Lugo, Emanuel Orozco, Christian Paul Torres de la Rosa

    Objectives: to evaluate feeding practices in the first year of life and their association with the development of overweight and obesity in children in Mexico. Methods: the association between overweight and obesity with different feeding practices were evaluated. The data was processed using the statistical package Stata version 14 using logistic regression models. Results: 396 children were evaluated; the prevalence of overweight and obesity was 6% and 7.7% presented a possible risk of overweight. 6.9% had exclusive breastfeeding in the first 6 months of life and 71.7% were fed infant formula. The variables significantly associated with the development of overweight and obesity in the first year of life were the age of the child (p =0.043, RR=0.57), the introduction of fluids in the first three days of life (p=0.02, RR=2.90), consumption of foods with a high sugar content (p =0.01, RR=0.25), consumption of milk other than breast (p =0.02, RR3.25) and egg consumption (p =0.05; RR=0.28). Conclusions: our results show that it is essential to attend complementary feeding practices and reinforce exclusive breastfeeding in the first year of life, as measures to prevent overweight and obesity to improve health in childhood.


  • Open Access

    DHA Supplementation of Obese Rats throughout Pregnancy and Lactation Modifies Milk Composition and Anxiety Behavior of Offspring

    by Elena Zambrano, Guadalupe L. Rodríguez-González, Luis A. Reyes-Castro, Claudia J. Bautista, Diana C. Castro-Rodríguez, Gimena Juárez-Pilares, Carlos A. Ibáñez, Alejandra Hernández-Rojas, Peter W. Nathanielsz, Sara Montaño, et al.

    We investigated if supplementing obese mothers (MO) with docosahexaenoic acid (DHA) improves milk long-chain polyunsaturated fatty acid (LCPUFA) composition and offspring anxiety behavior. From weaning throughout pregnancy and lactation, female Wistar rats ate chow (C) or a high-fat diet (MO). One month before mating and through lactation, half the mothers received 400 mg DHA kg−1 d−1 orally (C+DHA or MO+DHA). Offspring ate C after weaning. Maternal weight, total body fat, milk hormones, and milk nutrient composition were determined. Pups’ milk nutrient intake was evaluated, and behavioral anxiety tests were conducted. MO exhibited increased weight and total fat, and higher milk corticosterone, leptin, linoleic, and arachidonic acid (AA) concentrations, and less DHA content. MO male and female offspring had higher ω-6/ ω-3 milk consumption ratios. In the elevated plus maze, female but not male MO offspring exhibited more anxiety. MO+DHA mothers exhibited lower weight, total fat, milk leptin, and AA concentrations, and enhanced milk DHA. MO+DHA offspring had a lower ω-6/ω-3 milk intake ratio and reduced anxiety vs. MO. DHA content was greater in C+DHA milk vs. C. Supplementing MO mothers with DHA improves milk composition, especially LCPUFA content and ω-6/ω-3 ratio reducing offspring anxiety in a sex-dependent manner.


  • Open Access

    Gobernanza en el sistema de salud ante la pandemia por Covid-19 en México

    by Lina Díaz-Castro, María Guadalupe Ramírez-Rojas, Héctor Cabello-Rangel, Armando Arredondo, Ernesto Pablo Báscolo

    Objetivo. Analizar la gobernanza en el sistema de salud en México, en las políticas frente a la pandemia por Covid-19. Material y métodos. Estudio cualitativo, analítico, realizado entre junio y noviembre de 2020. Se analizaron 41 entrevistas semiestructuradas que se aplicaron a acto­res clave del sistema de salud y que se organizaron en el software ATLAS.ti 9. El análisis se adhirió a los principios teórico-metodológicos del Marco Analítico de Gobernanza. Resultados. El problema: la formulación de políticas fue centralizada; los actores: sólo los altos mandos participan en las decisiones; las normas: los valores sociales y el liderazgo determinan su nivel de responsabilidad; toma de decisio­nes: los altos mandos reconocieron poder para proponer modificaciones al Marco Normativo; los nodos: las políticas federales fueron adaptadas a nivel estatal de manera diferen­ciada. Conclusiones. La gobernanza centralizada, los niveles diferenciados de convocatoria de los actores, su poder de decisión, acuerdos, responsabilidad y liderazgo, definieron el alcance de la gobernanza y, a su vez, el nivel de respuesta ante la pandemia por Covid-19.